News About: Pharm. Industry
CPhI Korea becomes representative ‘International Pharmaceutical Event’
Held between the 23rd and 25th of August at the COEX, ‘CPhI Korea 2016’ settled as an international pharmaceutical event with substantiality, scale, participant satisfaction and reaction.
According to a hosting compa...
Will active ‘web symposium’ be a way for pharmaceuticals to promote their products?
Will the Kim Young-ran Law not be able to affect medical personnel’s academic activities that do not concern time and place?
In conclusion, supporting general academic activities itself is lawful, but assisting parti...
LG Life Sciences expect merger with LG ChemA merger of two companies, LG Life Sciences and LG Chem, is expected to be pushed.
On the 6th, LG Chem and LG Life Sciences officially announced they have not currently decided...
|
Domestic companies’ new trend to recruit directors with experience at multinational company
Along with popularity of expansion in global businesses and evidence-based academic marketing, domestic pharmaceutical companies have started to change their employment patterns.
Domestic pharmaceutical companies hav...
Multinational companies, “It is hard to find a Korean company not owning competing drugs”
“It is hard to select a partner since all the candidate companies have too many co-marketed products.”
Marketers at multinational pharmaceutical companies which are preparing to strengthen marketing for existing drug...
How their own employees think about enviable foreign pharmaceutical companies?
“We have too much overtime at night at Pfizer.” “Novartis blames on employees when an issue occurs.”
‘Foreign pharmaceutical companies’ are companies that pharmacy students, medical students and distinguished univers...
Korean new drug ‘Noltec’ draws series of interests from foreign markets
The value of the 14th Korean drug, ‘Noltec(Ilyang Pharmcaeutical),’ is being stressed again as getting interests from foreign markets. It has shown a favorable trend as entering in the top 5 of the Korean PPI agent ma...
Boksan Nice joining hands with Suzuken to consign pharmaceutical marketing
Boksan Nice declared a vision called ‘General Healthcare Company’ which provides differentiated services from other distribution companies. On a basis of the KRW 52 billion investment of Suzuken, a Japanese pharmaceut...
Successive KRW 1 trillion sale achievements in pharmaceutical industry
Including Yuhan Corporation, 4 pharmaceutical companies are expected to achieve KRW 1 trillion sales this year.
According to the analysis result of listed pharmaceutical companies’ sale performances in 2016, 3 compan...
Green Cross supplies largest amount of first-developed tetravalent flu vaccines
Green Cross, a loyal family in vaccine and the top influenza vaccine company, pushes forward with active moves to continue its reputation.
Green Cross(CEO Eun-cheol Huh) announced it successfully held a launching sym...
